Tandem Diabetes Care Affirms FY2026 Sales Guidance of $1.065B-$1.085B vs $1.072B Est
Benzinga Newsdesk 2 days ago
NewsGuidance
Tandem Diabetes Care (NASDAQ:TNDM) affirms FY2026 sales outlook from $1.065 billion-$1.085 billion to $1.065 billion-$1.085 billion vs $1.072 billion estimate.
Tandem Diabetes Care (NASDAQ:TNDM) affirms FY2026 sales outlook from $1.065 billion-$1.085 billion to $1.065 billion-$1.085 billion vs $1.072 billion estimate.